340 Improvement in haematologic parameters in patients with MDS treated with the iron chelator deferasirox (Exjade®): An EPIC study post-hoc analysis

Autor:	Bernard Roubert, Christian Rose, D. Vassilieff, Norbert Gattermann, Carlo Finelli, Michael Stadler, Mathias Schmid, Agnès Guerci-Bresler, Kerry Taylor, Andrea Marcellari, M.G. Della Porta, Pierre Fenaux, Dany Habr
Rok vydání:	2011
Předmět:	Oncology Iron Chelator Cancer Research medicine.medical_specialty business.industry Deferasirox Hematology Internal medicine Post-hoc analysis Medicine Epic study In patient business medicine.drug
Zdroj:	Leukemia Research. 35:S136-S137
ISSN:	0145-2126
DOI:	10.1016/s0145-2126(11)70342-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a1cfe898d2110f15d9d65d8d8b926d50 https://doi.org/10.1016/s0145-2126(11)70342-3 Zobrazit plný text záznamu Full Text from ScienceDirect